Article
Covaxin shows 50% effectiveness against symptomatic COVID-19 in real-world assessment, says Lancet study
Rating:
0.0
Views:
60
Likes:
1
Library:
1
The results of an interim study recently published in The Lancet showed that two doses of Covaxin had 77.8% efficacy against symptomatic disease and present no serious safety concerns
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value